Remove quality
article thumbnail

Quality risk management in radiopharmaceutical production

European Pharmaceutical Review

A paper published in Applied Sciences has described a quality risk assessment methodology for application in sterile PET radiopharmaceutical production under Good Manufacturing Practice (GMP) regulations. The quality risk assessment was performed by the research team before the new production process at the site began. Poli et al.

FDA 94
article thumbnail

Diabetes Health Burden Negatively Impacts Quality of Life in Elderly Patients

Drug Topics

A study published in Primary Care Diabetes pinpoints those at most risk and recommends education to improve the quality of life in diagnosed elderly patients.

209
209
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Influenza Vaccines: Is the Quality of Evidence the Same?

Drug Topics

In response to historically low flu vaccine coverage rates, Kristen Thorson, PharmD, urges pharmacists to think back to their pandemic immunization efforts and “know the power of their recommendation,” to boost public protection from influenza.

Vaccines 186
article thumbnail

Experts offer Medicare Advantage quality bonus program recommendations

Fierce Healthcare

A new-look Medicare Advantage (MA) quality bonus program would better incentivize insurers and help individuals choose a more appropriate plan, a report from Urban Institute finds. | A new report looks at how the Medicare Advantage quality bonus program could be improved, including taking the star ratings reporting private.

article thumbnail

FUJIFILM Diosynth recruits new Quality leader

European Pharmaceutical Review

Maja Pedersen has been appointed as Chief Quality Officer (CQO), to lead FUJIFILM Diosynth Biotechnologies’ global quality team. She explained: “I am thrilled to be joining FUJIFILM Diosynth Biotechnologies again and becoming an integral part of leading our teams to develop and embed a transformational quality culture.”

103
103
article thumbnail

Eli Lilly EVP of Global Quality to retire

European Pharmaceutical Review

Eli Lilly and Company’s Executive Vice President of Global Quality, Johna Norton, is ending her lengthy tenure with the company this summer and retiring after 34 years of service. “Johna’s career has been built on her commitment to ensuring that our medicines are produced with the highest quality standards. .

article thumbnail

Driving QbD as a quality standard in drug development

European Pharmaceutical Review

A paper published in the European Journal of Pharmaceutics and Biopharmaceutics has reviewed the current application status of Quality by Design (QbD) within the framework of the ICH guidelines (ICH Q8(R2) – Q14 and ICH Q2(R2)). It also lowers the regulatory burden too, the paper reported. [In For example, Simões et al.